About Us
The FTD Disorders Registry (Registry) is a non-profit resource designed to bring together all stakeholders who seek a solution for frontotemporal degeneration (FTD). We are here for persons diagnosed, family members, caregivers, and friends as well as clinicians, scientists, advocacy groups, and the pharma/biotech industry.
Our mission at the Registry is to facilitate research and accelerate the development of treatments by providing resources that:
- Promote & support research participation
- Enable access and sharing of data with researchers
- Amplify the voice of the patients’ and families’ lived experience
We support the spectrum of disorders that involve frontotemporal degeneration or FTD. Relevant clinical diagnoses include:
- Frontotemporal dementia
- behavioral variant FTD (bvFTD)
- primary progressive aphasia (PPA)
- progressive supranuclear palsy (PSP) or Richardson’s Syndrome
- corticobasal degeneration (CBD) / corticobasal syndrome (CBS)
- FTD with motor neuron disease (also called FTD-ALS)
The Registry provides a range of services.
Contact Registry — Everyone enrolled in the Registry has access to a private dashboard with information and a clinical research study list that can be filtered by interests. Participants can also receive communications such as newsletters or notifications about research studies recruiting for people that match their interests. Participation is open globally for persons 18 years old or older, including for friends and healthcare providers.
Research Study — The Registry also hosts an online research study to learn from people with lived experience with these disorders. People who are eligible and choose to participate will be invited to complete surveys, share medical records or genetic test results, and more. The data collected is stripped of identifying information (to maintain the privacy of participants) and then made available to researchers working towards solutions for people with these diseases. The online study is open to people:
- at least 18 years of age*
- who reside in the United States or Canada* (new geographic regions coming soon)
- who have direct lived experience with an FTD disorder as either a person diagnosed, a current or former caregiver, or a biological family member of someone who was diagnosed. A person-diagnosed can enroll themselves or be enrolled by their legally-authorized representative.
- able to actively participate in answering survey questions, even with the help of a care partner
*19 years in those states or provinces where the age of majority is 19
Other participation options: Some people are invited to participate in the Registry for specific purposes, such as to share insights on an enrolled person-diagnosed, or as part of their participation in a separate research study partnering with the Registry (e.g. the ALLFTD natural history study).
Participant privacy is a priority for our non-profit mission. Identifying information is never shared (See Privacy Policy and Personal Data Collection documents). Data collected and used for research purposes is de-identified to remove all personal information.
FOR HEALTHCARE PROVIDERS
We invite you to help the Registry and its resources reach the people who would like to learn more about research and possibly to participate. Information and flyers are available for families and persons diagnosed. Please contact Director@ftdregistry.org. We also invite you to join the Registry yourself.
FOR RESEARCH STAKEHOLDERS
The Registry offers resources to advance research. Please see “For Researchers” for more information.
HISTORY OF GROWTH
The FTD Registry was established in March 2015 as a shared vision between The Association for Frontotemporal Degeneration (AFTD) and The Bluefield Project to Cure Frontotemporal Dementia. We received nonprofit 501(c)(3) status in March 2016 and launched for public enrollment on March 28, 2017, giving birth to a shared vision to create a patient registry for the frontotemporal disorders (FTD) community.
When the Registry opened for enrollment on March 28, 2017, we exceeded our two-week goal of 100 registrants in less than 24 hours. Not only were enrollment goals broken on the first day, but also for each subsequent enrollment anniversary for the first five years. Through these years, the Registry has grown to include persons from all 50 U.S. states and more than 30 countries, with the majority of international participants residing in Canada, Australia, and the United Kingdom.
In 2024, the Registry relaunched on a transformed platform with new capabilities, new resources, and a new online research protocol to better meet the needs of FTD research and the community that we support. We invite you to join us.
STRATEGIC PLAN
We envision a world in which research on FTD is a robust, collaborative, and effective enterprise among researchers, persons diagnosed, care partners, and those at risk.
Read about our vision, mission, values, history, and more in our 2020-2022 Strategic Plan.
WORKING TOGETHER
The combined voices of our registrants empower the FTD Registry to inform on more patient-friendly clinical trial design and to stimulate new conversations with regulatory and policy groups as they work towards patient-focused drug development.
Learn how you can raise awareness about FTD and the FTD Disorders Registry and help make a difference in the lives of others.
About US
Together we can find a cure for ftd
The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.
Your privacy is important! We promise to protect it. We will not share your contact information.
CONNECT2CAREGIVERS
This 15-month remote study will help researchers determine whether caregivers of persons with dementia, including FTD, would find a technology-based matching program valuable for locating another caregiver for peer-to-peer support. Additionally to determine if algorithmic matches are more beneficial than random ones. Must be at least 18 years old, have access to the internet, and be a current or former caregiver who has been in the role of providing care for someone with dementia for at least 3 months.
For more information, visit the study listing on ClinicalTrials.gov.
Other Ways to Help
Spread the Word
Ask your family and friends to join in fighting FTD/Spectrum
Learn about FTD research
Why learn about FTD